跳至主要内容
临床试验/CTRI/2017/11/010651
CTRI/2017/11/010651进行中(未招募)2 期

Comparison of efficacy of aspirin plus Epirubicin,Oxaliplatin,Capecitabine(EOX)vs Epirubicin,Oxaliplatin,Capecitabine(EOX)alone in patients with locally advanced and metastatic gastric cancer-a randomised pilot trial

Jawaharlal Institute of Post graduate Medical education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Locally advanced and metastatic gastric cancer patients
  • 2. Performance status
  • 3. Able to take oral medications
  • 4. normal platelet counts

排除标准

  • 1. Significant organ dysfunction such as a.cardiac EF <50%, b.Serum creatinine >2mg/dl, c. Altered liver function-serum bilirubin >1.5mg/dl, AST/ALT >3xULN, ALP >5xULN
  • 2. previously on any dose of Aspirin
  • 3. Aspirin hypersensitivity

研究者

发起方
Jawaharlal Institute of Post graduate Medical education and Research

相似试验